The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A scoring system for selecting nivolumab or irinotecan in the later-line chemotherapy for advanced gastric cancer: A Japanese multicenter retrospective study.
 
Yusuke Amanuma
No Relationships to Disclose
 
Takeshi Suzuki
No Relationships to Disclose
 
Takeshi Kawakami
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb Japan; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Masahiko Aoki
No Relationships to Disclose
 
Yoshiyuki Yamamoto
Honoraria - Bayer; Bristol-Myers Squibb Japan; Daiichi Sankyo; Incyte Japan; Lilly; Merck Serono; Ono Pharmaceutical; SERVIER; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
 
Keitaro Shimozaki
No Relationships to Disclose
 
Hironaga Satake
Honoraria - Bayer; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Lilly Japan; Merck; MSD; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Daiichi Sankyo (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Masanori Nojima
Honoraria - Eisai
Consulting or Advisory Role - Alfresa; Chugai Pharma
 
Narikazu Boku
Honoraria - Bristol-Myers Squibb Japan; Daiichi-Sankyo; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Ono Pharmaceutical (Inst); Takeda (Inst)
 
Daisuke Takahari
Honoraria - Bristol-Myers Squibb Japan; Daiichi Sankyo/UCB Japan; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)